ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Oral Chinese patent medicines for diabetic kidney disease: An overview of systematic reviews

Xue, Xue; Li, Ke-ying; Liu, Shang-zhi; Li, Jia-xuan; Jin, Xin-yan; Liu, Xue-han; Lin, La-mei; Zou, Xin-rong; Lu, Chun-li; Zhao, Fang-fang; Liu, Jian-ping*; Wang, Xiao-qin*广东药学院; 1
European Journal of Integrative Medicine2023-8DOI: 10.1016/j.eujim.2023.102269
1被引38阅读
引用收藏
分享

摘要

Introduction: Diabetic kidney disease (DKD) has become a global public health problem with a significant disease burden. A number of Chinese patent medicines (CPMs) are widely used in the treatment of DKD in China. An overview of systematic reviews (SRs) can summarize the overall evidence of its effectiveness and safety for both practice and research. Methods: SRs and/or meta-analyses based on randomized controlled trials (RCTs) of oral CPMs for DKD were identified. Eight databases were searched from their inception to October 2021. The AMSTAR 2 tool was applied to appraise the methodological quality of the included SRs by two authors. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to summarize the certainty of evidence of the included reviews. Results: A total of 88 SRs were included, of which three were published as abstracts only (quality not assessed). The methodological quality using the AMSTAR 2 approach was assessed as "low" for five SRs and "critically low" for 80 SRs. Renal end-point events and quality of life were not reported in all SRs. Most of the reviews reported surrogate outcomes. Serum creatinine and 24 h urinary total protein were the two most commonly reported indicators, and regrettably, no high-quality evidence with GRADE assessment was found. Regarding safety, except for Tripterygium glycosides tablet which had several adverse effects, other CPMs had only mild adverse effects. Conclusion: Due to the lack of end-point outcomes and high-quality evidence, the effectiveness and safety of oral CPMs for DKD remain uncertain. Future studies with more critical methodological designs are needed to provide

学科与关键词

关键词
Diabetic kidney diseaseOral Chinese patent medicineOverviewSystematic reviewRandomized clinical trial
相关
加载中…
  • Renal-protective effects of Chinese medicinal herbs and compounds for diabetic kidney disease in animal models: protocol for systematic review and meta-analysis
    Liu, Meifang; Di, Yuan Ming; Zhang, Anthony Lin; Chen, Junhui; Wang, Ruobing; Huang, Juan; Zhang, Lei; Xue, Charlie Changli*; Liu, Xusheng*Systematic Reviews, 2024, 13(1): 23.
  • Effectiveness comparisons of traditional Chinese medicine on treating diabetic nephropathy proteinuria: A systematic review and meta-analysis.
    Wang, Lin; Wang, Ya-Hui; Zhang, Xian-Hui; Yang, Xue-Lian; Wei, Hui-Li; An, Zhi-Chao; Yu, Bo-Rui; Du, Da-Qing; Guo, Yan; Liu, Hong-FangMedicine (Baltimore), 2019, 98(43): e17495.
  • Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial
    Liu, Meifang; Di, Yuan Ming; Zhang, Lei; Yang, Lihong; Zhang, La; Chen, Junhui; Wang, Ruobing; Xie, Xiaoning; Lan, Fang; Xie, Liping; Huang, Juan; Zhang, Anthony Lin; Xue, Charlie Changli*; Liu, Xusheng*Frontiers in Endocrinology, 2024, 15: 1334609.
查看全部 →

发表信息

论文状态
公开发表
期刊
European Journal of Integrative Medicine
发表日期
2023-08
卷期
第 61 卷
页码
102269
DOI
10.1016/j.eujim.2023.102269
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074395]; Youth Project of the National Natural Science Foundation of China [82204989]; Xiamen Funds for Science and Technology Research [3502Z2021YJ12]; Natural Science Foundation of Hubei Province [2022CFC056]

作者

  • X

    Xue, Xue (第一作者)

    1 · hubei univ chinese med

  • L

    Li, Ke-ying

    hubei univ chinese med

查看全部 12 位作者收起作者
  • L

    Liu, Shang-zhi

    hubei univ chinese med

  • L

    Li, Jia-xuan

    hubei univ chinese med

  • J

    Jin, Xin-yan

    beijing univ tradit chinese med

  • L

    Liu, Xue-han

    beijing univ tradit chinese med

  • L

    Lin, La-mei

    hubei prov hosp tradit chinese med · hubei univ chinese med

  • Z

    Zou, Xin-rong

    hubei prov hosp tradit chinese med · hubei univ chinese med

  • L

    Lu, Chun-li

    guangdong pharmaceut univ · beijing univ tradit chinese med

  • Z

    Zhao, Fang-fang

    xiyuan hosp

  • L

    Liu, Jian-ping (通讯)

    beijing univ tradit chinese med

  • W

    Wang, Xiao-qin (通讯)

    hubei prov hosp tradit chinese med · hubei univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417